What the Options Market Tells Us About Novo Nordisk
What the Options Market Tells Us About Novo Nordisk
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $105.0 to $111.0, over the past month.Financial giants have made a conspicuous bearish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 14 unusual trades.
金融巨頭對諾和諾德（紐交所：NVO）採取了明顯的看淡行動。我們對諾和諾德的期權歷史分析顯示出14筆飛凡交易。
Delving into the details, we found 35% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $210,005, and 9 were calls, valued at $379,290.
深入細節後，我們發現35%的交易者持看好態度，而50%的交易者則表現出看淡傾向。在我們發現的所有交易中，有5筆是看跌期權，價值爲210,005美元，9筆是看漲期權，價值爲379,290美元。
Predicted Price Range
預測價格區間
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $111.0 for Novo Nordisk over the last 3 months.
考慮到這些合約的成交量和持倉量，似乎鯨魚在過去三個月針對諾和諾德的價格區間爲105.0美元到111.0美元。
Insights into Volume & Open Interest
成交量和持倉量分析
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Novo Nordisk's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Novo Nordisk's significant trades, within a strike price range of $105.0 to $111.0, over the past month.
檢查成交量和持倉量爲股票研究提供了重要洞察。這些信息是評估諾和諾德在特定行權價格的期權流動性和興趣水平的關鍵。以下是我們呈現的諾和諾德重要交易在105.0美元到111.0美元行權價格區間內的看漲和看跌期權的成交量和持倉量趨勢快照，涵蓋過去一個月。
Novo Nordisk 30-Day Option Volume & Interest Snapshot
諾和諾德30天期權成交量和興趣快照
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | CALL | SWEEP | NEUTRAL | 12/13/24 | $5.6 | $5.05 | $5.29 | $105.00 | $159.0K | 171 | 300 |
| NVO | PUT | TRADE | NEUTRAL | 12/20/24 | $8.35 | $8.0 | $8.2 | $110.00 | $42.6K | 7.0K | 273 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $8.2 | $8.1 | $8.1 | $110.00 | $42.1K | 7.0K | 116 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $8.2 | $8.1 | $8.1 | $110.00 | $42.1K | 7.0K | 64 |
| NVO | PUT | TRADE | BULLISH | 12/20/24 | $7.7 | $7.5 | $7.5 | $109.00 | $42.0K | 351 | 56 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVO | 看漲 | SWEEP | 中立 | 12/13/24 | $5.6 | $5.05 | $5.29 | $105.00 | $159.0K | 171 | 300 |
| NVO | 看跌 | 交易 | 中立 | 12/20/24 | $8.35 | $8.0 | $8.2 | $110.00 | $42.6K | 7.0K | 273 |
| NVO | 看跌 | 交易 | BULLISH | 12/20/24 | $8.2 | $8.1 | $8.1 | $110.00 | $42.1K | 7.0K | 279 |
| NVO | 看跌 | 交易 | BULLISH | 12/20/24 | $8.2 | $8.1 | $8.1 | $110.00 | $42.1K | 7.0K | 64 |
| NVO | 看跌 | 交易 | BULLISH | 12/20/24 | $7.7 | $7.5 | $7.5 | $109.00 | $42.0千 | 351 | 56 |
About Novo Nordisk
諾和諾德是一家領先的全球醫療保健公司，致力於研發創新藥品，幫助患糖尿病的患者過上更長壽、更健康的生活，這一傳統已有100多年。這種傳統爲我們提供了經驗和能力，使我們能夠推動變革，幫助人們戰勝其他嚴重的慢性疾病，如肥胖症、罕見的血液和內分泌紊亂。我們始終堅信，持久的成功公式是保持專注，長遠思考，並以財務、社會和環境負責任的方式做生意。諾和諾德在新澤西州設有美國總部，在7個州加上華盛頓特區擁有商業、生產和研究設施，在全國約有8000名員工。有關更多信息，訪問novonordisk-us.com，Facebook、Instagram和X。
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
作爲全球治療糖尿病品牌市場三分之一的領先者，丹麥的Novo Nordisk公司是世界上提供糖尿病護理產品的主要製造商和市場推廣者。該公司製造和銷售各種人體和現代胰島素、GLP-1療法等可注射糖尿病治療藥物、口服降糖藥以及肥胖症治療藥物。Novo Nordisk還有一個生物製藥部門（約佔營收的10%），專門從事血友病和其他疾病的蛋白質療法。
Where Is Novo Nordisk Standing Right Now?
Novo Nordisk現在處於什麼位置？
- Trading volume stands at 358,592, with NVO's price down by -0.65%, positioned at $105.44.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 61 days.
- 交易量爲358,592，NVO的價格下跌了-0.65%，目前報105.44美元。
- RSI指標顯示該股票目前處於超買和超賣之間的中立狀態。
- 預計在61天內公佈業績。
Expert Opinions on Novo Nordisk
諾和諾德專家意見
1 market experts have recently issued ratings for this stock, with a consensus target price of $160.0.
1名市場專家最近爲這支股票發出評級，共識目標價爲160.0美元。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動：智慧資金在行動。
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* An analyst from Cantor Fitzgerald downgraded its action to Overweight with a price target of $160.
Benzinga Edge的期權異動板塊能在市場變動發生前識別潛在的市場動向。查看大資金在您喜歡的股票上的持倉情況。點擊這裏獲取訪問權限。* 一位來自Cantor Fitzgerald的分析師將其評級下調至增持，目標價定爲160美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。
